ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
4DMEDICAL LTD
3.740
+0.300
8.72%
成交量:
528.71萬
成交額:
1,931.42萬
市值:
22.50億
市盈率:
-10.93
高:
3.760
開:
3.520
低:
3.490
收:
3.440
52周最高:
7.550
52周最低:
1.400
股本:
6.02億
流通股本:
3.78億
量比:
1.71
換手率:
1.40%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.342
每股收益(LYR):
-0.342
淨資產收益率:
-174.43%
總資產收益率:
-15.62%
市淨率:
13.22
市盈率(LYR):
-10.93
資料載入中...
總覽
公司
新聞資訊
公告
4DMedical獲澳大利亞TGA批准CTVQ技術
投资观察
·
06/26
異動解讀 | 4DMedical推出臨床證據計劃,股價盤中大漲5.38%
异动解读
·
06/02
4DMedical推出明確臨床證據計劃,旨在加速Ct:Vq™進入急性肺栓塞市場
美股速递
·
06/02
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/4DX.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"4DX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","market":"AU","secType":"STK","nameCN":"4DMEDICAL LTD","latestPrice":3.74,"timestamp":1789452720000,"preClose":3.44,"halted":0,"volume":5287057,"delay":0,"changeRate":0.08720930232558148,"nameEN":"4DMEDICAL LTD","floatShares":377762864,"shares":601571602,"eps":-0.342118,"marketStatus":"未開盤","change":0.3,"latestTime":"09-15 16:12:00 AEST","open":3.52,"high":3.76,"low":3.49,"amount":19314152,"amplitude":0.078488,"askPrice":3.74,"askSize":1650,"bidPrice":3.54,"bidSize":1412,"shortable":3,"etf":0,"ttmEps":-0.342118,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":3.44,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":1.711287,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"4DX.AU","preClose":3.44,"auctionPrice":3.74,"auctionVolume":148656,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452615337}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","floatShares":377762864,"roa":"-15.62%","roe":"-174.43%","lyrEps":-0.342118,"volumeRatio":1.711287,"shares":601571602,"dividePrice":0,"high":3.76,"amplitude":0.078488,"preClose":3.44,"low":3.49,"week52Low":1.4,"pbRate":"13.22","psRate":"318.61","week52High":7.55,"institutionHeld":0,"latestPrice":3.74,"committee":-0.077727,"eps":-0.342118,"divideRate":0,"volume":5287057,"delay":0,"ttmEps":-0.342118,"open":3.52,"prevYearClose":3.93,"prevWeekClose":3.36,"prevMonthClose":3.42,"prevQuarterClose":4.53,"fiveDayClose":3.35,"twentyDayClose":3.76,"sixtyDayClose":4.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/4DX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"4DX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"4DX.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1127775213","title":"4DMedical獲澳大利亞TGA批准CTVQ技術","url":"https://stock-news.laohu8.com/highlight/detail?id=1127775213","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127775213?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 09:37","pubTimestamp":1782437859,"startTime":"0","endTime":"0","summary":"4DMedical Ltd宣布,其CTVQ技术已获得澳大利亚治疗商品管理局的批准。这一监管进展为该公司在澳大利亚市场的业务拓展奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149159643","title":"異動解讀 | 4DMedical推出臨床證據計劃,股價盤中大漲5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149159643","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149159643?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 08:03","pubTimestamp":1780358589,"startTime":"0","endTime":"0","summary":"4DMedical有限公司(股票代码:4DX.AU)今日盘中大涨5.38%,引起了市场的关注。消息面上,公司宣布启动一项明确的临床证据计划,该计划旨在为其Ct:Vq™技术加速进入急性肺栓塞(PE)市场铺平道路,这被视为一项积极的业务进展,增强了投资者对公司未来增长潜力的信心。该临床证据计划的核心目标是通过生成坚实的临床数据,来支持这项创新技术在关键医疗领域的应用与采纳,市场预期此举将有助于公司拓展新的市场机会。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146205447","title":"4DMedical推出明確臨床證據計劃,旨在加速Ct:Vq™進入急性肺栓塞市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1146205447","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146205447?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 06:32","pubTimestamp":1780353139,"startTime":"0","endTime":"0","summary":"4DMedical有限公司宣布启动一项明确的临床证据计划,该计划旨在为其Ct:Vq™技术加速进入急性肺栓塞(PE)市场铺平道路。该计划的核心目标是通过生成坚实的临床数据,来支持这项创新技术在关键医疗领域的应用与采纳。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}